Wednesday, July 2, 2025

Biome Analytics Introduces AI-Powered Documentation Audit Product to Enhance Cardiovascular Data Accuracy and Revenue Optimization

Related stories

Blaize Raises $56M for Edge AI in Southeast Asia’s Infra

Blaize, a leader in edge AI computing, has secured...

Formant F3 Adds Gen AI, Agentic Reasoning to Robot Ops

Formant has announced the debut of F3, an AI-native...

CustomerInsights.AI Launches ciATHENA, an AI Platform for Pharma Analytics

CIAI announced the launch of ciATHENA, a next generation Agentic...

PhaseV Unveils ClinOps AI for Smarter Trial Site Picks

Powered by Causal AI and Real-Time Patient-Level Data and...

Accenture Acquires SYSTEMA to Boost Semiconductor Automation

Accenture has acquired SYSTEMA, a provider of software solutions...
spot_imgspot_img

Biome Analytics, the leader in cardiovascular performance improvement solutions, is pleased to announce the launch of its latest innovation, the Biome Risk Audit. Developed to address challenges in risk reporting and documentation accuracy in cardiovascular care, this artificial intelligence (AI) enabled tool integrates traditionally siloed quality data and billing information to improve publicly reported outcomes and maximize revenue opportunities.

The Biome Risk Audit solves longstanding challenges with risk reporting and documentation accuracy. By comparing manually abstracted quality data with billing/coding data, this solution enables healthcare organizations to capture patient risk more accurately, improve quality rankings, and maximize reimbursement.

Also Read: Sagility Acquires BirchAI, a GenAI Company in the Healthcare Space

“At Biome, we understand the critical importance of accurate risk reporting and documentation in cardiovascular care,” says Matthew Esham, Biome’s Vice President of Analytics. “Our Bi-Directional Risk Audit Engine provides cardiovascular teams with practical tools to enhance documentation accuracy and revenue, saving healthcare teams hundreds of hours.”

One early-release client identified a 37% under-documentation of comorbidities like diabetes. Another client improved their observed-to-expected ratio by 30%. Both organizations realized revenue and margin improvements in just one-quarter of usage.

SOURCE: BusinessWire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img